OTCBB: BZEC - Mackay Life Sciences, Inc.


Overview | Members (5)

OTCBB: BZEC - Mackay Life Sciences, Inc.

Overview

5 Members |created September 22, 2009
Biofield Diagnostic System (BDS) is a proprietary technology that detects breast cancer at its negative stage. The Mackay Life Sciences, Inc. is the brain behind BDS.

Group Portfolio

-
A group portfolio has not been created.

Discussions

-


User avatar

IMO get BZEC now at $0.12

0 stars

0.5 stars
October 12, 2009 03:30 pm
Hey guys, in my opinion you should start taking a look at the symbol OTCBB:BZEC. I heard there's a news about a buy-out to be announced very soon. The company is on the actual process of documentation and finalization. I do believe that once the... buy-out between an AIM-listed company happened...
0 Replies

Discussions

-


Be the first to post on this discussion.